World Health Organization. (2022). Leishmaniasis: Fact Sheet. Geneva: WHO Press.
[2]
Alvar, J., et al. (2012). The Relationship between Leishmaniasis and AIDS: the Second 10 Years. Clinical Microbiology Reviews, 25(2), 295-312.
[3]
Murray, H. W., et al. (2005). Treatment of Visceral Leishmaniasis. Clinical Infectious Diseases, 41(6), 915-916.
[4]
Reithinger, R., et al. (2007). Cutaneous Leishmaniasis. The Lancet Infectious Diseases, 7(9), 581-596.
[5]
Singh, O. P., et al. (2016). Immunotherapy for Treating Visceral Leishmaniasis. Expert Opinion on Biological Therapy, 16(4), 491-503.
[6]
Bates, P. A. (2007). Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies. International Journal for Parasitology, 37(10), 1097-1106.
[7]
Kevric, I., et al. (2015). The Burden of Neglected Tropical Diseases. PLoS Neglected Tropical Diseases, 9(4), e0003658.
[8]
Goto, H., & Lauletta Lindoso, J. A. (2012). Cutaneous and Mucocutaneous Leishmaniasis. Infectious Disease Clinics of North America, 26(2), 293-307.